Delirium, thrombocytopenia, insomnia, and mild liver damage associated with MAOI withdrawal

European Journal of Clinical Pharmacology

Volumn 65, Issue 12, 2009, Pages 1269-1270

  Bellon, Alfredo ^a   Coverdale, John H ^b  

^a CENTRE DE PSYCHIATRIE ET NEUROSCIENCES   (France)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CHLORPROMAZINE; TRANYLCYPROMINE;

ADULT; CASE REPORT; CLINICAL EVALUATION; DELIRIUM; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; EVENING DOSAGE; FEMALE; HEPATOGRAPHY; HUMAN; INSOMNIA; LETTER; LIVER FUNCTION TEST; LIVER INJURY; MAJOR DEPRESSION; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; THROMBOCYTOPENIA; WITHDRAWAL SYNDROME;

ADULT; DELIRIUM; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; MONOAMINE OXIDASE INHIBITORS; SLEEP INITIATION AND MAINTENANCE DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME; THROMBOCYTOPENIA; TRANYLCYPROMINE;

EID: 71349084926     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-009-0711-y     Document Type: Letter

References (18)

1. GRK Parker K Wilhelm P Mitchell 2001 Assessing the comparative effectiveness of antidepressant therapies: a prospective clinical practice study J Clin Psychiatry 62 2 17 125
2. JW Stewart ME Thase 2007 Treating DSM-IV depression with atypical features J Clin Psychiatry 68 4 e10 10.4088/JCP.0407e10 17474800
3. M Adli M Pilhatsch M Bauer U Koberle R Ricken G Janssen, et al. 2008 Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression Pharmacopsychiatry 41 6 252 257 10.1055/s-0028-1083819 1:CAS:528: DC%2BD1MXitVWgs7k%3D 19067263
4. NC Briggs JW Jefferson FH Koenecke 1990 Tranylcypromine addiction: a case report and review J Clin Psychiatry 51 10 426 429 1:STN:280: DyaK3M%2FgvFSitg%3D%3D 2211541
5. E Davids J Roschke C Klawe G Grunder A Schmoldt 2000 Tranylcypromine abuse associated with delirium and thrombocytopenia J Clin Psychopharmacol 20 2 270 271 10.1097/00004714-200004000-00026 1:STN:280:DC%2BD3c3jtFansw%3D%3D 10770472 (Pubitemid 30202376)
6. SC Dilsaver 1988 Monoamine oxidase inhibitor withdrawal phenomena: symptoms and pathophysiology Acta Psychiatr Scand 78 1 1 7 10.1111/j.1600-0447. 1988.tb06293.x 1:STN:280:DyaL1M%2Fit1Smtw%3D%3D 2845711
7. SC Dilsaver 1990 Heterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena Prog Neuropsychopharmacol Biol Psychiatry 14 2 137 161 10.1016/0278-5846(90)90097-Z 1:STN:280:DyaK3c7nsF2itw%3D%3D 1968671
8. A Chatterjee MC Tosyali 1995 Thrombocytopenia and delirium associated with tranylcypromine overdose J Clin Psychopharmacol 15 2 143 144 10.1097/00004714-199504000-00013 1:STN:280:DyaK2MzgtFOgug%3D%3D 7782490
9. A Szelenyi J Albrecht 1998 Tranylcypromine abuse associated with an isolated thrombocytopenia Pharmacopsychiatry 31 6 238 240 10.1055/s-2007-979336 1:STN:280:DyaK1M7islygsg%3D%3D 9930640
10. C Bandt FW Hoffbauer 1964 Liver injury associated with tranylcypromine therapy JAMA 188 752 753 1:STN:280:DyaF2c%2FotVCgsw%3D%3D 14122685
11. JL Le Gassicke ED AshcroftGW JJ Evans I Oswald EB Riston 1965 The clinical state, sleep and amine metabolism of tranylcypromine ('Parnate') addict Br J Psychiatry 111 357 364 10.1192/bjp.111.473.357
12. O Ben-Arie GC George 1979 A case of tranylcypromine ('Parnate') addiction Br J Psychiatry 135 273 274 10.1192/bjp.135.3.273 1:STN:280: DyaL3c%2FitFOgsg%3D%3D 486854
13. KT Brady RB Lydiard C Kellner 1991 Tranylcypromine abuse Am J Psychiatry 148 9 1268 1269 1:STN:280:DyaK3MzltlOqsw%3D%3D 1883016
14. J Davidson S Pelton 1986 Forms of atypical depression and their response to antidepressant drugs Psychiatry Res 17 2 87 95 10.1016/0165-1781(86)90063-6 1:STN:280:DyaL287nvVWiuw%3D%3D 3083445 (Pubitemid 16175043)
15. A Kayser DS Robinson A Nies D Howard 1985 Response to phenelzine among depressed patients with features of hysteroid dysphoria Am J Psychiatry 142 4 486 488 1:STN:280:DyaL2M7ks1emsQ%3D%3D 3883817
16. B Shopsin NS Kline 1976 Monoamine oxidase inhibitors: potential for drug abuse Biol Psychiatry 11 4 451 456 1:STN:280:DyaE2s%2FgtVGnsA%3D%3D 963135
17. D Vartzopoulos F Krull 1991 Dependence on monoamine oxidase inhibitors in high dose Br J Psychiatry 158 856 857 10.1192/bjp.158.6.856 1:STN:280:DyaK3MzjvV2isQ%3D%3D 1873639
18. Y Fujita K Takahashi M Takei, et al. 2008 Detection of levorotatory methamphetamine and levorotatory amphetamine in urine after ingestion of an overdose of selegiline Yakugaku Zasshi 128 10 1507 1512 10.1248/yakushi.128.1507 1:CAS:528:DC%2BD1cXhsVGks7jJ 18827472